Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1987-8-19
|
pubmed:abstractText |
The physiological role of calcitonin is still uncertain. Recently human calcitonin gene-related peptide, produced by alternative RNA processing from the calcitonin gene, was shown to have structural homology to salmon calcitonin and probably have a modulator function in the hypothalamus. In this study, salmon calcitonin was infused at a low dose (10 MRC units over 30 min) in seven patients with impaired renal function (51-Cr-EDTA clearance = 34.8 +/- 4.8 ml/min) in order to elucidate its effects on PRL secretion. The results show that salmon calcitonin at a subhypocalcaemic dose significantly suppresses PRL secretion by over 40% (P less than 0.01) and may be of therapeutic use in the treatment of gonadal dysfunction in chronic renal failure.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0001-5598
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
243-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3604555-Adult,
pubmed-meshheading:3604555-Calcitonin,
pubmed-meshheading:3604555-Female,
pubmed-meshheading:3604555-Glomerulonephritis,
pubmed-meshheading:3604555-Humans,
pubmed-meshheading:3604555-Hyperprolactinemia,
pubmed-meshheading:3604555-Infusions, Intravenous,
pubmed-meshheading:3604555-Kidney Failure, Chronic,
pubmed-meshheading:3604555-Male,
pubmed-meshheading:3604555-Middle Aged
|
pubmed:year |
1987
|
pubmed:articleTitle |
Reduction of serum prolactin after salmon calcitonin infusion in patients with impaired renal function.
|
pubmed:publicationType |
Journal Article
|